Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression—transcriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway
Authors:
- Tae-Wook ChungTCTae-Wook Chung
- Sung-Koo KangSKSung-Koo Kang
- Young-Choon LeeYLYoung-Choon Lee
- Jeong-Heon KoJKJeong-Heon Ko
- Jong-Guk KimJKJong-Guk Kim
- Cheorl-Ho KimCheorl-Ho Kim
Open Access
- 30 March 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 16 (7) , 573-583
Abstract
The simple ganglioside GM3 has been shown to have anti-proliferative effects in several in vitro and in vivo cancer models. Although the exogenous ganglioside GM3 has an inhibitory effect on cancer cell proliferation, the exact mechanism by which it prevents cell proliferation remains unclear. Previous studies showed that MDM2 is an oncoprotein that controls tumorigenesis through both p53-dependent and p53-independent mechanisms, and tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a dual-specificity phosphatase that antagonizes phosphatidylinositol 3-kinase (PI-3K)/AKT signaling, is capable of blocking MDM2 nuclear translocation and destabilizing the MDM2 protein. Results from our current study show that GM3 treatment dramatically increases cyclin-dependent kinase (CDK) inhibitor (CKI) p21WAF1 expression through the accumulation of p53 protein by the PTEN-mediated inhibition of the PI-3K/AKT/MDM2 survival signaling in HCT116 colon cancer cells. Moreover, the data herein clearly show that ganglioside GM3 induces p53-dependent transcriptional activity of p21WAF1, as evidenced by the p21WAF1 promoter-driven luciferase reporter plasmid (full-length p21WAF1 promoter and a construct lacking the p53-binding sites). Additionally, ganglioside GM3 enhances expression of CKI p27kip1 through the PTEN-mediated inhibition of the PI-3K/AKT signaling. Furthermore, the down-regulation of the cyclin E and CDK2 was clearly observed in GM3-treated HCT116 cells, but the down-regulation of cyclin D1 and CDK4 was not. On the contrary, suppression of PTEN levels by RNA interference restores the enhanced expression of p53-dependent p21WAF1 and p53-independent p27kip1 through inactivating the effect of PTEN on PI-3K/AKT signaling modulated by ganglioside GM3. These results suggest that ganglioside GM3-stimulated PTEN expression modulates cell cycle regulatory proteins, thus inhibiting cell growth. We conclude that ganglioside GM3 represents a modulator of cancer cell proliferation and may have potential for use in colorectal cancer therapy.Keywords
This publication has 49 references indexed in Scilit:
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomasOncogene, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Mechanisms through Which Gangliosides Inhibit PDGF-Stimulated Mitogenesis in Intact Swiss 3T3 Cells: Receptor Tyrosine Phosphorylation, Intracellular Calcium, and Receptor BindingExperimental Cell Research, 1993
- Incorporation of ganglioside analogs into fibroblast cell membranes. A spin-label studyBiochemistry, 1983
- Biosynthesis and Function of GangliosidesScience, 1976